BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11290431)

  • 21. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU.
    Isshi K; Sakuyama T; Gen T; Nakamura Y; Kuroda T; Katuyama T; Maekawa Y
    Int J Clin Oncol; 2002 Dec; 7(6):335-42. PubMed ID: 12494248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
    Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
    Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in the dihydropyrimidine dehydrogenase expression of colorectal cancers.
    Yamashita K; Mikami Y; Ikeda M; Yamamura M; Kubozoe T; Urakami A; Yoshida K; Kimoto M; Tsunoda T
    Cancer Lett; 2002 Dec; 188(1-2):231-6. PubMed ID: 12406569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Fukushima M; Minamigawa K; Takano T; Kobayashi H
    Lung Cancer; 2001 Dec; 34(3):407-16. PubMed ID: 11714538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?
    Milano G; McLeod HL
    Eur J Cancer; 2000 Jan; 36(1):37-42. PubMed ID: 10741292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine.
    Ikeguchi M; Hirooka Y; Makino M; Kaibara N
    Oncol Rep; 2001; 8(3):621-5. PubMed ID: 11295091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M; Takechi T; Okabe H; Fukushima M
    Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.
    Mattison LK; Soong R; Diasio RB
    Pharmacogenomics; 2002 Jul; 3(4):485-92. PubMed ID: 12164772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells.
    Yasumatsu R; Nakashima T; Uryu H; Masuda M; Hirakawa N; Shiratsuchi H; Tomita K; Fukushima M; Komune S
    Oral Oncol; 2009 Feb; 45(2):141-7. PubMed ID: 18620897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients.
    Katona C; Kralovánszky J; Rosta A; Pandi E; Fónyad G; Tóth K; Jeney A
    Oncology; 1998; 55(5):468-74. PubMed ID: 9732227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.
    Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Renée N; Milano G
    Eur J Cancer; 1994; 30A(10):1517-22. PubMed ID: 7833111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
    Humerickhouse RA; Dolan ME; Haraf DJ; Brockstein B; Stenson K; Kies M; Sulzen L; Ratain MJ; Vokes EE
    Clin Cancer Res; 1999 Feb; 5(2):291-8. PubMed ID: 10037177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dihydropyrimidine dehydrogenase activity and its genetic aberrations].
    Ogura K
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1041-8. PubMed ID: 16912518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydropyrimidine dehydrogenase levels in nonsmall-cell lung cancer tissues.
    Yano T; Koga T; Ninomiya S; Takeo S
    Int J Clin Oncol; 2002 Dec; 7(6):361-4. PubMed ID: 12494252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].
    Loriot MA; Ciccolini J; Thomas F; Barin-Le-Guellec C; Royer B; Milano G; Picard N; Becquemont L; Verstuyft C; Narjoz C; Schmitt A; Bobin-Dubigeon C; Harle A; Paci A; Poinsignon V; Quaranta S; Evrard A; Hennart B; Broly F; Fonrose X; Lafay-Chebassier C; Wozny AS; Masskouri F; Boyer JC; Etienne-Grimaldi MC
    Bull Cancer; 2018 Apr; 105(4):397-407. PubMed ID: 29486921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
    Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
    Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydropyrimidine dehydrogenase activity and mRNA expression in advanced gastric cancer analyzed in relation to effectiveness of preoperative 5-fluorouracil-based chemotherapy.
    Takabayashi A; Iwata S; Kawai Y; Kanai M; Taki Y; Takechi T; Fukushima M
    Int J Oncol; 2000 Nov; 17(5):889-95. PubMed ID: 11029488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
    Milano G; Chamorey AL
    Chronobiol Int; 2002 Jan; 19(1):177-89. PubMed ID: 11962674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer.
    Yu Z; Yang Q; Sun J; Zhen J
    Exp Oncol; 2007 Sep; 29(3):192-6. PubMed ID: 18004243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [5-fluorouracil and dihydropyrimidine dehydrogenase].
    Kubota T
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):433-9. PubMed ID: 11329775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.